Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    January 2019
  1. GRAY V, Briggs S, Palles C, Jaeger E, et al
    Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
    J Natl Cancer Inst. 2019 Jan 14. pii: 5289445. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  2. JU HQ, Lu YX, Chen DL, Zuo ZX, et al
    Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.
    J Natl Cancer Inst. 2018 Dec 8. pii: 5236681. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  3. BARRY EL, Fedirko V, Baron JA
    NSAIDs and Colorectal Cancer Phenotypes: What Now?
    J Natl Cancer Inst. 2018 Nov 2. pii: 5156227. doi: 10.1093.
    PubMed     Text format    


  4. AMITAY EL, Carr PR, Jansen L, Walter V, et al
    Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
    J Natl Cancer Inst. 2018 Nov 2. pii: 5156228. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  5. OH M, McBride A, Yun S, Bhattacharjee S, et al
    BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018 Oct 31. pii: 5151259. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. CHOI YH, Lakhal-Chaieb L, Krol A, Yu B, et al
    Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
    J Natl Cancer Inst. 2018 Oct 30. pii: 5149368. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. HAMADA T, Nowak JA, Masugi Y, Drew DA, et al
    Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127125. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  8. SCHMIT SL, Edlund CK, Schumacher FR, Gong J, et al
    Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
    J Natl Cancer Inst. 2018 Jun 16. pii: 5039592. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. MCCULLOUGH ML, Zoltick ES, Weinstein SJ, Fedirko V, et al
    Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
    J Natl Cancer Inst. 2018 Jun 14. pii: 5035027. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  10. LOREE JM, Bailey AM, Johnson AM, Yu Y, et al
    Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.
    J Natl Cancer Inst. 2018 Apr 27. pii: 4989438. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  11. COGHILL AE, Engels EA, Schymura MJ, Mahale P, et al
    Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
    J Natl Cancer Inst. 2018 Feb 26. pii: 4911376. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  12. ARAGHI M, Fidler MM, Arnold M, Jemal A, et al
    The Future Burden of Colorectal Cancer Among US Blacks and Whites.
    J Natl Cancer Inst. 2018 Jan 23. pii: 4822521. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. MARISA L, Svrcek M, Collura A, Becht E, et al
    The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  14. MLECNIK B, Van den Eynde M, Bindea G, Church SE, et al
    Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  15. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  16. HANLEY CJ, Mellone M, Ford K, Thirdborough SM, et al
    Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    December 2017
  17. SJOQUIST KM, Renfro LA, Simes RJ, Tebbutt NC, et al
    Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
    J Natl Cancer Inst. 2017 Dec 18. pii: 4757465. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. FOKAS E, Strobel P, Fietkau R, Ghadimi M, et al
    Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  19. PIETRANTONIO F, Di Nicolantonio F, Schrock AB, Lee J, et al
    ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    August 2017
  20. MURPHY CC, Sanoff HK, Stitzenberg KB, Baron JA, et al
    RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  21. MOLENAAR RJ, Radivoyevitch T, Wilmink JW
    RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: